Leptin, a peripherally produced polypeptide, causes weight loss after crossing the blood-brain barrier (BBB) to enter the brain where it is considered to exert a major regulatory function in obesity. Paradoxically, in obesity blood levels of leptin are increased, resulting in what has been called """"""""leptin resistance,"""""""" accompanied by relatively low levels of leptin in the cerebrospinal fluid (CSF). It has been proposed that the mechanism causing this """"""""resistance"""""""" is decreased passage of leptin across the BBB by the transport system we have described in non-obese animals. Here, we shall use well-established techniques to determine the pharmacokinetics of the transport of leptin across the BBB in rodents with dietary, genetic, and lesioned obesity. Quantification will involve multiple-time regression analysis and perfusion. HPLC will ensure that the material entering the brain is intact and capillary depletion, with washout, will ensure that leptin does not remain bound to the endothelium. Albumin will be co-injected to correct for leakage and non- specific passage. Saturability, the self-inhibition of transport, will be determined with unlabeled leptin. Autoradiography with quantitative image analysis will determine in obese animals the sites of localization of the leptin transporters, which will be isolated and identified, and their activity (energy and ion dependence) determined in cerebral endothelia cells. Preliminary results already support our hypothesis that the transport of leptin across the BBB is decreased in some forms of obesity. Although this defect might not explain all forms of """"""""leptin resistance"""""""" in obesity, the transport system for leptin across the BBB does provide an appropriate target of regulatory control that is susceptible to experimental and eventual therapeutic manipulation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK054880-03
Application #
6329429
Study Section
Special Emphasis Panel (ZRG1-BDCN-2 (01))
Program Officer
Smith, Philip F
Project Start
1999-04-01
Project End
2003-11-30
Budget Start
2000-12-01
Budget End
2001-11-30
Support Year
3
Fiscal Year
2001
Total Cost
$321,158
Indirect Cost
Name
Tulane University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
New Orleans
State
LA
Country
United States
Zip Code
70118
He, Yi; Cornelissen-Guillaume, Germaine G; He, Junyun et al. (2016) Circadian rhythm of autophagy proteins in hippocampus is blunted by sleep fragmentation. Chronobiol Int 33:553-60
Wang, Yuping; Hsuchou, Hung; He, Yi et al. (2015) Role of Astrocytes in Leptin Signaling. J Mol Neurosci 56:829-839
Pan, Weihong (2015) From blood to brain through BBB and astrocytic signaling. Peptides 72:121-7
He, Junyun; Kastin, Abba J; Wang, Yuping et al. (2015) Sleep fragmentation has differential effects on obese and lean mice. J Mol Neurosci 55:644-52
Ouyang, Suidong; Hsuchou, Hung; Kastin, Abba J et al. (2014) Diet-induced obesity suppresses expression of many proteins at the blood-brain barrier. J Cereb Blood Flow Metab 34:43-51
He, Junyun; Hsuchou, Hung; He, Yi et al. (2014) Sleep restriction impairs blood-brain barrier function. J Neurosci 34:14697-706
Pan, Weihong; Kastin, Abba J (2014) Leptin: a biomarker for sleep disorders? Sleep Med Rev 18:283-90
Pan, Weihong; Kastin, Abba J (2014) Can sleep apnea cause Alzheimer's disease? Neurosci Biobehav Rev 47:656-69
He, Junyun; Wang, Yuping; Kastin, Abba J et al. (2014) Increased sleep fragmentation in experimental autoimmune encephalomyelitis. Brain Behav Immun 38:53-8
Ouyang, Suidong; Hsuchou, Hung; Kastin, Abba J et al. (2014) Leukocyte infiltration into spinal cord of EAE mice is attenuated by removal of endothelial leptin signaling. Brain Behav Immun 40:61-73

Showing the most recent 10 out of 122 publications